Revenue: The sum of all revenue fields included for a company's operating activities.
Allergy Therapeutics (AGYTF) had Revenue of $69.52M for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
|
Revenue |
$69.52M |
$-50.65M |
|
$32.07M |
|
$37.45M |
|
$113.92M |
|
$-44.40M |
|
$-4.92M |
|
$-49.33M |
|
$-49.33M |
|
$-50.65M |
|
$-50.65M |
|
$-50.65M |
|
$-50.65M |
|
$-44.40M |
|
$-38.96M |
|
3.74B |
|
3.74B |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$42.17M |
|
$20.51M |
|
$39.48M |
|
$81.64M |
|
$25.87M |
|
$36.36M |
|
$51.10M |
|
$76.97M |
|
$4.67M |
|
$-1.23M |
|
$4.67M |
|
4.78B |
|
| Cash Flow Statement Financials | |
$-40.47M |
|
$-1.51M |
|
$39.58M |
|
$18.70M |
|
$16.27M |
|
$-2.43M |
|
$0.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.63 |
|
-- |
|
-- |
|
0.89 |
|
8.35 |
|
53.87% |
|
-63.87% |
|
-63.87% |
|
-56.05% |
|
-70.95% |
|
-72.86% |
|
$-44.76M |
|
-- |
|
-- |
|
-- |
|
0.85 |
|
2.00 |
|
7.06 |
|
51.73 |
|
-1084.29% |
|
4112.08% |
|
-62.04% |
|
-123.43% |
|
$0.00 |
|
$-0.01 |
|
$-0.01 |
|